Pierre Fabre United States of America Canada France Germany Spain United Kingdom

Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

View original content:https://www.prnewswire.co.uk/news-releases/pierre-fabre-laboratories-to-accelerate-their-development-in-onco-hematology-by-acquiring-the-license-for-a-breakthrough-t-cell-immunotherapy-in-north-america-301976479.html